Daniel Anderson
Internal Medicine · Powell, TNNPI 1104112705
Payments from drug & device makers
Across 136 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$481
- Novo Nordisk$306
- Lilly USA, LLC$304
- Takeda Pharmaceuticals U.S.A., Inc.$145
- Amgen$122
- Boston Scientific$105
- plus $653 from 17 others
What the payments were for
- Food & beverage$2,116100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 34 | $481 |
| Novo Nordisk | 22 | $306 |
| Lilly USA, LLC | 22 | $304 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $145 |
| Amgen(2 entities) | 9 | $122 |
| Boston Scientific | 3 | $105 |
| AstraZeneca | 4 | $95 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Astellas Pharma US Inc | 3 | $55 |
| Boehringer Ingelheim | 4 | $54 |
| Merck | 3 | $47 |
| Exeltis, USA Inc. | 3 | $46 |
| Novartis | 3 | $46 |
| Bayer | 2 | $41 |
| Eisai Inc. | 3 | $40 |
| Abbott | 2 | $37 |
| Pfizer | 2 | $29 |
| Tolmar, Inc. | 1 | $24 |
| Medtronic | 1 | $19 |
| Polynovo North America LLC | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Chiesi USA, Inc. | 1 | $14 |
How this compares
$2,116 in reported general payments places this provider in the 75th percentile of 2,216 internal medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 71 | $72,889 |
| OzempicSemaglutide | 62 | $57,473 |
| FarxigaDapagliflozin Propanediol | 68 | $45,037 |
| EliquisApixaban | 65 | $41,407 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 39 | $26,493 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $24,426 |
| JanuviaSitagliptin Phosphate | 27 | $23,602 |
| LinzessLinaclotide | 20 | $19,228 |
| UbrelvyUbrogepant | 16 | $18,633 |
| JardianceEmpagliflozin | 19 | $18,349 |
| Tresiba Flextouch U-200Insulin Degludec | 22 | $16,678 |
| Spiriva RespimatTiotropium Bromide | 23 | $15,273 |
| VascepaIcosapent Ethyl | 22 | $9,213 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 29 | $7,156 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 319 | $6,202 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $304 | $72,88971 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $95 | $71,530107 claims |
| Novo NordiskOzempic | $306 | $57,47362 claims |
| PfizerEliquis | $29 | $41,40765 claims |
| AbbVieLinzess, Ubrelvy | $481 | $37,86136 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $54 | $33,62242 claims |
| MerckJanuvia | $47 | $23,60227 claims |
| Astellas Pharma US IncMyrbetriq | $55 | $5,46812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,216 internal medicine providers in Tennessee.
Other internal medicine in Powell
- Mark McKenzieChattanooga$11.9M
- Bernard GrunstraBristol$6.4M
- Jewel WhiteKingsport$5.7M
- Judith WhiteKingsport$5.6M
- Obadias MarquezOoltewah$2.8M
- Amanda Moore MillerKnoxville$2.3M
- Rick WhilesBristol$1.5M
- John AndersonNashville$1.5M
- David MorinKingsport$1.4M
- John KirbyJefferson City$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.